EIKEN CHEMICAL CO.,LTD. (4549) Income statement

Market cap
¥108B
P/E ratio
44.6x
Manufactures and sells diagnostic reagents for the medical field through operations in Japan and China, with plans to expand into the American market.
2012/032013/032014/032015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/032026/03
Revenue27,70228,64530,02731,01432,16333,27434,99135,76136,58538,66742,99643,27140,05240,53941,899
Revenue growth (%)-
Cost of revenue---18,14718,76119,11020,29020,06920,35520,13722,43122,76523,32824,02725,729
Gross profit---12,86713,40214,16314,70115,69216,22918,52920,56420,50616,72316,51216,138
Gross margin (%)---
Operating margin (%)---
Operating expenses ---10,0419,86610,18611,22011,08011,60811,91412,18413,04913,34513,51213,176
Operating income ---2,8263,5363,9763,4784,6114,6226,6128,3877,4573,3772,9992,919
Income before tax 2,5432,8123,0953,0133,5704,1123,5494,6814,7236,8088,5087,5683,5683,1982,844
Pretax margin (%)9.29.810.39.711.112.410.113.112.917.619.817.58.97.96.8
Provision for income taxes---9049609268651,2011,1851,8252,2631,8568697631,125
Effective tax rate (%)---
Net income 1,4222,4011,9592,1002,4292,9182,6083,4473,5385,0446,2185,7362,6342,2283,024
Earnings per share80.38134.98109.13115.13132.85159.3971.2193.6395.95136.65168.28155.1771.6964.82112.52
Diluted EPS79.66133.56107.84113.85131.43157.670.3492.8495.21135.6167.01153.8671.164.27-
Dividend payout ratio (%)---------
Dividend per share--------30415151515358
AI Chat